The International CAR T-cell therapy market is experiencing a period of exponential growth. This expansion can be attributed to several factors, including the rising prevalence of cancer, advances in immunotherapy, and favorable regulatory sanctions. The market is categorized by classification of CAR T-cell therapy, use, level of therapy, and regio